Hubbard Radio Washington DC, LLC. All rights reserved. This website is not intended for users located within the European Economic Area.
Regenxbio: Q4 Earnings Snapshot
ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — Regenxbio Inc. (RGNX) on Tuesday reported a loss of $59.9 million in its fourth quarter.
On a per-share basis, the Rockville, Maryland-based company said it had a loss of $1.38.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.48 per share.
The biotechnology company posted revenue of $31.3 million in the period, which...
ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — Regenxbio Inc. (RGNX) on Tuesday reported a loss of $59.9 million in its fourth quarter.
On a per-share basis, the Rockville, Maryland-based company said it had a loss of $1.38.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.48 per share.
The biotechnology company posted revenue of $31.3 million in the period, which missed Street forecasts. Four analysts surveyed by Zacks expected $35.7 million.
For the year, the company reported a loss of $280.3 million, or $6.50 per share. Revenue was reported as $112.7 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGNX at https://www.zacks.com/ap/RGNX
Copyright © 2023 . All rights reserved. This website is not intended for users located within the European Economic Area.
The latest in Government Events powered by:
